None listed
Conditions
Brief summary
Shoulder pain is a common and debilitating symptom for a large number of people following a stroke. The cause of shoulder pain is usually related to several factors, including trauma, inflammation and positioning. In cases when shoulder pain is unable to be prevented, current treatment options include arm supports, physiotherapy techniques, and simple analgesic medication. It is commonly observed that shoulder pain persists or is inadequately controlled by these interventions. This research aims to study the effect of an injection that numbs the nerve (Suprascapular Nerve) that supplies pain fibres to the shoulder. The technique has previously been proven safe and effective in the treatment of shoulder pain associated with rheumatoid arthritis and degenerative shoulder conditions.
Interventions
The intervention group will receive injection into the arm of suprascapular nerve blocking (using depo-medrol 40mg and 0.5% bupivivocaine hydrochloride).
Sponsors
Maria Crotty
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Inclusion criteria will be all willing patients aged over 18 years and able to give consent with a diagnosis of acute stroke with the previous 12 months and onset of hemiplegic shoulder pain post stroke with a visual analogue scale score of >30mm (100mm scale)
Exclusion criteria
Cognitive deficit that preclude patients from reliably using subjective outcome measures scales - Mini-Mental State Examination (MMSE) < 23. Language deficits (inability to follow 2- stage command) or limited English language that preclude patients from reliably using subjective outcome measures scales Allergy to proposed injection agents (depo-medrol 40mg and 0.5% bupivocaine hydrocholoride)
Outcome results
None listed